SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus

Insights

Coronavirus Disease-2019 (COVID-19) infection and treatments may reactivate Kaposi's sarcoma-associated herpesvirus (KSHV). This increases cancer risk in KSHV-positive patients, even after COVID-19 recovery.

Area of Science:

  • Virology
  • Oncology
  • Infectious Diseases

Background:

  • The novel coronavirus SARS-CoV-2 causes COVID-19, a global pandemic with significant mortality and socioeconomic impact.
  • Pathogenesis and host cell infection mechanisms of SARS-CoV-2 are not fully understood, lacking specific antiviral treatments and vaccines.
  • Comorbidities can worsen COVID-19 outcomes, necessitating research into its effects on pre-existing conditions like cancer and other infections.

Approach:

  • Investigated the impact of SARS-CoV-2 proteins and anti-COVID-19 drugs on Kaposi's sarcoma-associated herpesvirus (KSHV).
  • Examined the manipulation of intracellular signaling pathways by SARS-CoV-2 and related drugs.
  • Assessed the risk of virus-associated cancers in KSHV-positive individuals exposed to COVID-19 or its treatments.

Key Points:

  • SARS-CoV-2 proteins and certain anti-COVID-19 medications can induce lytic reactivation of KSHV, a human oncogenic virus.
  • Reactivation occurs through the manipulation of intracellular signaling pathways.
  • KSHV-positive patients exposed to COVID-19 or its treatments face elevated risks for developing virus-associated cancers.

Conclusions:

  • COVID-19 infection and its treatments pose a potential risk for KSHV reactivation.
  • This reactivation may lead to an increased incidence of KSHV-associated malignancies.
  • KSHV-positive individuals, particularly those in endemic areas, require careful monitoring for cancer development post-COVID-19 exposure or treatment.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.9K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.6K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
911
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
38.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.1K
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
997